Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linzagolix Extension Study for Endometriosis Pain (EDELWEISS 6)
NCT04335591Phase 3Completed
- Sponsor
- Kissei Pharmaceutical Co., Ltd.
- Start
- Mar 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of linzagolix in endometriosis, sponsored by Kissei Pharmaceutical Co., Ltd.. Started Mar 2020; status: completed.
02
Drugs
linzagolix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT04335591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04335591.